Compass Therapeutics (CMPX) Profit After Tax: 2023-2025
Historic Profit After Tax for Compass Therapeutics (CMPX) over the last 3 years, with Sep 2025 value amounting to -$14.3 million.
- Compass Therapeutics' Profit After Tax fell 36.05% to -$14.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$65.8 million, marking a year-over-year decrease of 37.79%. This contributed to the annual value of -$49.4 million for FY2024, which is 16.19% down from last year.
- As of Q3 2025, Compass Therapeutics' Profit After Tax stood at -$14.3 million, which was up 28.28% from -$19.9 million recorded in Q2 2025.
- Compass Therapeutics' 5-year Profit After Tax high stood at -$7.8 million for Q1 2023, and its period low was -$19.9 million during Q2 2025.
- In the last 3 years, Compass Therapeutics' Profit After Tax had a median value of -$13.1 million in 2024 and averaged -$13.0 million.
- Data for Compass Therapeutics' Profit After Tax shows a maximum YoY tumbled of 54.19% (in 2025) over the last 5 years.
- Compass Therapeutics' Profit After Tax (Quarterly) stood at -$13.4 million in 2023, then decreased by 12.06% to -$15.0 million in 2024, then crashed by 36.05% to -$14.3 million in 2025.
- Its last three reported values are -$14.3 million in Q3 2025, -$19.9 million for Q2 2025, and -$16.6 million during Q1 2025.